Liraglutide abrogates nephrotoxic effects of chemotherapies

Acute kidney injury (AKI) is a common clinical complication. Cisplatin (Cis) is an effective chemotherapeutic drug; however, its acute nephrotoxicity often limits its application. The role of liraglutide (Lir), an agonist of the glucagon-like peptide-1 receptor (GLP-1R), has recently attracted incre...

Cijeli opis

Bibliografski detalji

Glavni autori:	Cong Xu, Chenqi Lu, Zhimin Wang, Xiaofan Hu, Shanglin Li, Yanan Xie, Yang Qiu, Rui Cao, Yakun Li, Jun Yang
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-03-01
Serija:	Pharmacological Research
Teme:	Acute kidney injury Cisplatin Liraglutide GLP-1R Metabolite HMGB1
Online pristup:	http://www.sciencedirect.com/science/article/pii/S1043661823000361
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!